Companies can improve their chances for a successful transition by leveraging their knowledge of their medical devices and understanding what each device’s categorization under the MDR means to its testing strategy.
New health-related data is arriving almost daily. Making sense of it all is a huge challenge.
Although medical device manufacturers have more time to prepare due to the delayed EU MDR deadline, this shouldn’t distract from the extensive documentation they must compile in the meantime to prove their devices are compliant.
During the current operating environment there has been an increased need for healthcare training using patient simulators for students and practicing healthcare professionals.
In order to meet the worldwide need for faster and affordable testing processes, companies must shift goals and apply resources to ending this pandemic.
While connected capabilities and wireless technology certainly lead to greater patient care, they also expose devices to greater cybersecurity risks.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
As the proliferation of connected and complex medical devices grows, healthcare providers are more susceptible to cyberattacks.
Networks enable the use of critical resources, including telehealth services, medical IoT technology,and staff and personal devices. It is critical to have a reliable WiFi network to support these devices.
The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.